Compare TVTX & DOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TVTX | DOO |
|---|---|---|
| Founded | N/A | 1937 |
| Country | United States | Canada |
| Employees | N/A | 17000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.4B |
| IPO Year | 2013 | N/A |
| Metric | TVTX | DOO |
|---|---|---|
| Price | $58.16 | $62.13 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | $40.62 | ★ $85.67 |
| AVG Volume (30 Days) | ★ 2.2M | 221.6K |
| Earning Date | 05-04-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 1.21% |
| EPS Growth | ★ 92.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $44.76 | $8.48 |
| Revenue Next Year | $35.51 | $5.10 |
| P/E Ratio | ★ N/A | $338.95 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.36 | $48.83 |
| 52 Week High | $60.10 | $81.89 |
| Indicator | TVTX | DOO |
|---|---|---|
| Relative Strength Index (RSI) | 74.06 | 60.09 |
| Support Level | $41.75 | $60.02 |
| Resistance Level | N/A | $63.86 |
| Average True Range (ATR) | 2.35 | 1.96 |
| MACD | 0.61 | 0.23 |
| Stochastic Oscillator | 86.03 | 74.41 |
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
BRP designs, develops, manufactures, distributes, and markets snowmobiles, all-terrain vehicles, and personal watercraft under the Ski-Doo, Sea-Doo, Can-Am, and Lynx brand names. It also builds engines under the Rotax brand (after shuttering the Evinrude outboard engine business in 2020) and offers clothing, parts, and accessories that cater to its core consumers. In 2018, BRP created a marine group, which has largely been divested; Manitou was sold in the third quarter of fiscal 2026, and Telwater remains up for sale. At the end of fiscal 2026, the company sold its products through a network of more than 2,050 independent dealers and 140 distributors in around 110 countries.